Shanghai Securities: Multiple factors empower the rapid development of the brain-computer interface industry; focus on technology and commercialization implementation

Shanghai Securities released a research report stating that the country's first non-invasive brain-computer interface clinical research project has completed filing under Order No. 818, marking that China's cutting-edge non-invasive brain-computer interface technology has officially entered a new stage of standardized clinical research, which is of milestone significance. The institution believes that brain-computer interfaces are gradually achieving a key leap from laboratory proof-of-concept to clinical translation and industrial implementation, and the track continues to show a trend of "policy support intensifying + technological breakthroughs + capital influx," with multiple factors empowering the industry's development to enter the fast lane.